RATIONALE: Contextual control over drug relapse depends on the successful reconsolidation and retention of context-response-cocaine associations in long-term memory stores. The basolateral amygdala (BLA) plays a critical role in cocaine memory reconsolidation and subsequent drug context-induced cocaine-seeking behavior; however, less is known about the cellular mechanisms of this phenomenon. OBJECTIVES: The present study evaluated the hypothesis that protein kinase A (PKA) and calcium/calmodulin-dependent protein kinase II (CaMKII) activation in the BLA is necessary for the reconsolidation of context-response-cocaine memories that promote subsequent drug context-induced cocaine-seeking behavior. METHODS: Rats were trained to lever-press for cocaine infusions in a distinct context, followed by extinction training in a different context. Rats were then briefly re-exposed to the previously cocaine-paired context or an unpaired context in order to reactivate cocaine-related contextual memories and initiate their reconsolidation or to provide a similar behavioral experience without explicit cocaine-related memory reactivation, respectively. Immediately after this session, rats received bilateral microinfusions of vehicle, the PKA inhibitor, Rp-adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt (Rp-cAMPS), or the CaMKII inhibitor, KN-93, into the BLA or the posterior caudate putamen (anatomical control region). Rats were then tested for cocaine-seeking behavior (responses on the previously cocaine-paired lever) in the cocaine-paired context and the extinction context. RESULTS: Intra-BLA infusion of Rp-cAMPS, but not KN-93, following cocaine memory reconsolidation impaired subsequent cocaine-seeking behavior in a dose-dependent, site-specific, and memory reactivation-dependent fashion. CONCLUSIONS: PKA, but not CaMKII, activation in the BLA is critical for cocaine memory re-stabilization processes that facilitate subsequent drug context-induced instrumental cocaine-seeking behavior.
RATIONALE: Contextual control over drug relapse depends on the successful reconsolidation and retention of context-response-cocaine associations in long-term memory stores. The basolateral amygdala (BLA) plays a critical role in cocaine memory reconsolidation and subsequent drug context-induced cocaine-seeking behavior; however, less is known about the cellular mechanisms of this phenomenon. OBJECTIVES: The present study evaluated the hypothesis that protein kinase A (PKA) and calcium/calmodulin-dependent protein kinase II (CaMKII) activation in the BLA is necessary for the reconsolidation of context-response-cocaine memories that promote subsequent drug context-induced cocaine-seeking behavior. METHODS:Rats were trained to lever-press for cocaine infusions in a distinct context, followed by extinction training in a different context. Rats were then briefly re-exposed to the previously cocaine-paired context or an unpaired context in order to reactivate cocaine-related contextual memories and initiate their reconsolidation or to provide a similar behavioral experience without explicit cocaine-related memory reactivation, respectively. Immediately after this session, rats received bilateral microinfusions of vehicle, the PKA inhibitor, Rp-adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt (Rp-cAMPS), or the CaMKII inhibitor, KN-93, into the BLA or the posterior caudate putamen (anatomical control region). Rats were then tested for cocaine-seeking behavior (responses on the previously cocaine-paired lever) in the cocaine-paired context and the extinction context. RESULTS: Intra-BLA infusion of Rp-cAMPS, but not KN-93, following cocaine memory reconsolidation impaired subsequent cocaine-seeking behavior in a dose-dependent, site-specific, and memory reactivation-dependent fashion. CONCLUSIONS:PKA, but not CaMKII, activation in the BLA is critical for cocaine memory re-stabilization processes that facilitate subsequent drug context-induced instrumental cocaine-seeking behavior.
Authors: S Grant; E D London; D B Newlin; V L Villemagne; X Liu; C Contoreggi; R L Phillips; A S Kimes; A Margolin Journal: Proc Natl Acad Sci U S A Date: 1996-10-15 Impact factor: 11.205
Authors: Molly E Eaton; Wendy Macías; Rachael M Youngs; Anjali Rajadhyaksha; Joshua T Dudman; Christine Konradi Journal: Brain Res Mol Brain Res Date: 2004-11-24
Authors: Rita A Fuchs; K Allison Evans; Christopher C Ledford; Macon P Parker; Jordan M Case; Ritu H Mehta; Ronald E See Journal: Neuropsychopharmacology Date: 2005-02 Impact factor: 7.853
Authors: E Lax; A Friedman; R Massart; R Barnea; L Abraham; D Cheishvili; M Zada; H Ahdoot; T Bareli; G Warhaftig; L Visochek; M Suderman; M Cohen-Armon; M Szyf; G Yadid Journal: Mol Psychiatry Date: 2016-09-06 Impact factor: 15.992
Authors: Amy A Arguello; Rong Wang; Carey M Lyons; Jessica A Higginbotham; Matthew A Hodges; Rita A Fuchs Journal: Psychopharmacology (Berl) Date: 2017-05-02 Impact factor: 4.530
Authors: S J Stringfield; J A Higginbotham; R Wang; A L Berger; R J McLaughlin; R A Fuchs Journal: Neuropharmacology Date: 2017-05-23 Impact factor: 5.250
Authors: Jessica A Higginbotham; Rong Wang; Ben D Richardson; Hiroko Shiina; Shi Min Tan; Mark A Presker; David J Rossi; Rita A Fuchs Journal: J Neurosci Date: 2020-11-30 Impact factor: 6.167
Authors: Jobe L Ritchie; Jennifer L Walters; Justine M C Galliou; Robert J Christian; Shuyi Qi; Marina I Savenkova; Christopher K Ibarra; Shayna R Grogan; Rita A Fuchs Journal: Neuropharmacology Date: 2021-10-02 Impact factor: 5.250
Authors: Matthew T Rich; Thomas B Abbott; Lisa Chung; Erol E Gulcicek; Kathryn L Stone; Christopher M Colangelo; TuKiet T Lam; Angus C Nairn; Jane R Taylor; Mary M Torregrossa Journal: J Neurosci Date: 2016-07-20 Impact factor: 6.167